European trends in breast cancer mortality, 1980-2017 and predictions to 2025
- PMID: 34062485
- DOI: 10.1016/j.ejca.2021.04.026
European trends in breast cancer mortality, 1980-2017 and predictions to 2025
Abstract
Background: Breast cancer mortality in European women has been falling for three decades. We analysed trends in mortality from breast cancer in Europe over the period 1980-2017 and predicted number of deaths and rates to 2025.
Methods: We extracted death certification data for breast cancer in women for 35 European countries, between 1980 and 2017, from the World Health Organisation database. We computed the age-standardised (world standard population) mortality rates per 100,000 person-years, by country and calendar year. We obtained also predictions for 2025 using a joinpoint regression model and calculated the number of avoided deaths over the period 1994-2025.
Results: The mortality rate declined from 15.0 in 2012 to 14.4 in 2017 per 100,000 women (-3.9%) for the European Union (EU)-27. This fall was greater in the EU-14 (-5.2%), whereas rates rose in the transitional countries during this period by 1.9%. Mortality rate predictions across Europe are expected to reach relatively uniform levels in 2025. During the studied period, favourable trends in mortality emerged in most countries, with the greatest decrease in Denmark, whereas Poland and Romania showed an upward trend. The largest predicted decrease in breast cancer mortality was estimated for the United Kingdom (12.2/100,000 women in 2025), leading to the estimated avoidance of 150,000 breast cancer deaths over the period 1994-2025 and 470,000 in the EU-27.
Conclusions: Favourable trends in breast cancer mortality were observed in most European countries, and they will continue to fall in the coming years. Less favourable patterns were still observed among the transitional countries than other European areas.
Keywords: Breast cancer; Europe; Mortality; Projections; Trends.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Conflict of interest statement The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.
Similar articles
-
Trends and predictions to 2020 in breast cancer mortality in Europe.Breast. 2017 Dec;36:89-95. doi: 10.1016/j.breast.2017.06.003. Epub 2017 Oct 4. Breast. 2017. PMID: 28988610
-
European cancer mortality predictions for the year 2019 with focus on breast cancer.Ann Oncol. 2019 May 1;30(5):781-787. doi: 10.1093/annonc/mdz051. Ann Oncol. 2019. PMID: 30887043
-
European trends in ovarian cancer mortality, 1990-2020 and predictions to 2025.Eur J Cancer. 2023 Nov;194:113350. doi: 10.1016/j.ejca.2023.113350. Epub 2023 Sep 26. Eur J Cancer. 2023. PMID: 37837925
-
European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?Ann Oncol. 2015 Apr;26(4):779-786. doi: 10.1093/annonc/mdv001. Epub 2015 Jan 26. Ann Oncol. 2015. PMID: 25623049
-
Trends in male breast cancer mortality: a global overview.Eur J Cancer Prev. 2021 Nov 1;30(6):472-479. doi: 10.1097/CEJ.0000000000000651. Eur J Cancer Prev. 2021. PMID: 33470692 Review.
Cited by
-
Trends in breast cancer mortality in Peru and its geographical areas from 2013 to 2022 and prediction until 2027.BMC Cancer. 2025 Mar 13;25(1):463. doi: 10.1186/s12885-025-13872-z. BMC Cancer. 2025. PMID: 40082828 Free PMC article.
-
Breast Cancer Mortality in the Americas and Australasia over the Period 1980-2017 with Predictions for 2025.Biology (Basel). 2021 Aug 23;10(8):814. doi: 10.3390/biology10080814. Biology (Basel). 2021. PMID: 34440046 Free PMC article.
-
Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysis.ESMO Open. 2023 Jun;8(3):101214. doi: 10.1016/j.esmoop.2023.101214. Epub 2023 Apr 17. ESMO Open. 2023. PMID: 37075698 Free PMC article.
-
A Life course approach to investigate breast cancer and migration in the greater Paris area: the SENOVIE study protocol.BMJ Open. 2025 Apr 2;15(4):e095759. doi: 10.1136/bmjopen-2024-095759. BMJ Open. 2025. PMID: 40180375 Free PMC article.
-
Mammography screening and incidence of ductal carcinoma in situ of the breast in Italy: an age-period-cohort analysis.Int J Epidemiol. 2025 Jun 11;54(4):dyaf102. doi: 10.1093/ije/dyaf102. Int J Epidemiol. 2025. PMID: 40557614 Free PMC article.